Autres langues 908 Devices Inc.

Actions

MASS

US65443P1021

Temps réel estimé Cboe BZX Autres places de cotation 21:37:26 06/05/2024			Varia. 5j.	Varia. 1 janv.
5,54 ^USD	-1,95%		-3,56%	-50,53%

30/04	Transcript : 908 Devices Inc., Q1 2024 Earnings Call, Apr 30, 2024
30/04	908 Devices Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Earnings Flash (MASS) 908 DEVICES Posts Q1 Revenue $10M	30/04
908 Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook	30/04
908 Devices Inc. Provides Revenue Guidance for the Full Year 2024	30/04
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering	30/04
908 Devices Inc. acquired CAM2 Technologies, LLC for $76.6 million.	30/04
Cam2 Technologies, LLC announced that it has received $45 million in funding from 908 Devices Inc.	29/04
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024	23/04
Die Technologie zur Identifizierung chemischer Spuren von 908 Devices wird von europäischen Behörden eingeführt	12/03
908 Devices Trace Chemical Identification Technology Adopted by European Agencies	12/03
908 Devices Inc. Trace Chemical Identification Technology Adopted by European Agencies	12/03
908 Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
Earnings Flash (MASS) 908 DEVICES Reports Q4 Revenue $14.4M	05/03
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook	05/03
908 Devices Inc. Provides Earnings Guidance for the Full Year 2024	05/03
North American Morning Briefing : S&P 500 Futures -2-	05/03
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares' Fully Integrated Cell Therapy Manufacturing Platform	01/03
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform	29/02
908 Devices to Participate in Upcoming Investor Conferences	22/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues 908 Devices Inc.

Actions

MASS

US65443P1021

Autres langues

Filtres